tiprankstipranks
Advertisement
Advertisement

OSTX Stock Latest News

OS Therapies Ends At-The-Market Equity Sales Program
Company AnnouncementsOS Therapies Ends At-The-Market Equity Sales Program
5d ago
8K
OSTX
OS Therapies terminates At Market Issuance Sales Agreement
PremiumThe Fly
OS Therapies terminates At Market Issuance Sales Agreement
5d ago
OSTX
OS Therapies initiated with a Buy at Roth Capital
PremiumThe Fly
OS Therapies initiated with a Buy at Roth Capital
26d ago
OSTX
OS Therapies Secures Convertible Note Financing for Expansion
PremiumCompany Announcements
OS Therapies Secures Convertible Note Financing for Expansion
1M ago
8K
OSTX
OS Therapies price target lowered to $13 from $14 at Lake Street
PremiumThe Fly
OS Therapies price target lowered to $13 from $14 at Lake Street
3M ago
OSTX
OS Therapies Delays Quarterly SEC Filing
PremiumCompany AnnouncementsOS Therapies Delays Quarterly SEC Filing
3M ago
OSTX
OS Therapies Gains EMA Rolling Review for OST-HER2
Premium
Company Announcements
OS Therapies Gains EMA Rolling Review for OST-HER2
3M ago
8K
OSTX
OSTX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
OSTX Earnings this Week: How Will it Perform?
4M ago
OSTX
OS Therapies bolsters funding to advance OST-HER2 program
PremiumCompany Announcements
OS Therapies bolsters funding to advance OST-HER2 program
4M ago
8K
OSTX
Regulatory Momentum and De-Risked Path to Accelerated Approval Support Buy Rating on OST-HER2 Osteosarcoma Program
PremiumRatings
Regulatory Momentum and De-Risked Path to Accelerated Approval Support Buy Rating on OST-HER2 Osteosarcoma Program
4M ago
OSTX
OS Therapies price target lowered to $14 from $17 at Lake Street
PremiumThe Fly
OS Therapies price target lowered to $14 from $17 at Lake Street
4M ago
OSTX
OS Therapies Files Prospectus Supplement for Share Resale
PremiumCompany Announcements
OS Therapies Files Prospectus Supplement for Share Resale
4M ago
8K
OSTX
OS Therapies Raises $2 Million via Convertible Notes
PremiumCompany AnnouncementsOS Therapies Raises $2 Million via Convertible Notes
5M ago
8K
OSTX
OS Therapies Extends Warrant Inducement Offering Period
Premium
Company Announcements
OS Therapies Extends Warrant Inducement Offering Period
6M ago
8K
OSTX
OS Therapies Raises Capital Through Warrant Inducement Agreements
Premium
Company Announcements
OS Therapies Raises Capital Through Warrant Inducement Agreements
7M ago
8K
OSTX
Promising Outlook for OS Therapies: Buy Rating Backed by Positive FDA Meeting and Strategic Positioning
PremiumRatings
Promising Outlook for OS Therapies: Buy Rating Backed by Positive FDA Meeting and Strategic Positioning
8M ago
OSTX
OS Therapies price target lowered to $17 from $18 at Lake Street
PremiumThe Fly
OS Therapies price target lowered to $17 from $18 at Lake Street
9M ago
OSTX
OS Therapies Reports Increased Losses Amid Rising R&D Costs
PremiumCompany Announcements
OS Therapies Reports Increased Losses Amid Rising R&D Costs
9M ago
OSTX
OSTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
OSTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
9M ago
OSTX
OS Therapies Approves Key Proposals at Annual Meeting
PremiumCompany AnnouncementsOS Therapies Approves Key Proposals at Annual Meeting
10M ago
8K
OSTX
OS Therapies Releases Investor Presentation for Stakeholders
Premium
Company Announcements
OS Therapies Releases Investor Presentation for Stakeholders
10M ago
8K
OSTX
Promising Regulatory Progress and Market Potential Justify Buy Rating for OS Therapies’ OST-HER2
Premium
Ratings
Promising Regulatory Progress and Market Potential Justify Buy Rating for OS Therapies’ OST-HER2
10M ago
OSTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >